Cargando…

Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy

Expression of transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF) in patients with Achilles tendon rupture, and the predictive values and significance in clinical efficacy were explored. Forty-two patients with Achilles tendon rupture, surgically treated in the First...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Juncheng, Chen, Zhiwei, Wu, Wente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777322/
https://www.ncbi.nlm.nih.gov/pubmed/31602226
http://dx.doi.org/10.3892/etm.2019.7968
_version_ 1783456606908841984
author Cui, Juncheng
Chen, Zhiwei
Wu, Wente
author_facet Cui, Juncheng
Chen, Zhiwei
Wu, Wente
author_sort Cui, Juncheng
collection PubMed
description Expression of transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF) in patients with Achilles tendon rupture, and the predictive values and significance in clinical efficacy were explored. Forty-two patients with Achilles tendon rupture, surgically treated in the First Affiliated Hospital of University of South China, were selected and the clinical efficacy was evaluated based on the American Orthopaedic Foot and Ankle Society (AOFAS) scoring system. RT-qPCR was adopted to detect the expression of serum TGF-β1 and VEGF in the patients before and after treatment, and Spearman's correlation was used to analyze the correlation of TGF-β1 and VEGF with the clinical efficacy after treatment. Patients were divided into an excellent efficacy group and a good/general efficacy group according to the predictive efficacy. In the two groups, the expression levels of TGF-β1 and VEGF before treatment were observed, and the predictive values of TGF-β1 and VEGF in clinical efficacy using the receiver operating characteristic (ROC) curves were obtained. The 42 patients showed significantly higher expression of TGF-β1 and VEGF at 3 months after treatment, and significantly decreased expression at 6 months after treatment, compared to the results before treatment (both P<0.001). After treatment, the efficacy was excellent in 11 patients, good in 25 and general in 6. Spearman's correlation analysis revealed that the expression of TGF-β1 and VEGF decreased with the improvement of efficacy after treatment (P<0.001), and the excellent efficacy group showed significantly lower expression of TGF-β1 and VEGF than that in the good/general efficacy group (P<0.01). Moreover, according to ROC curves, the areas under the curves (AUCs) of TGF-β1 and VEGF were 0.651 and 0.645, respectively. In conclusion, TGF-β1 and VEGF can be considered as observational indexes and predictors for clinical efficacy in patients with Achilles tendon rupture, before and after treatment.
format Online
Article
Text
id pubmed-6777322
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-67773222019-10-10 Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy Cui, Juncheng Chen, Zhiwei Wu, Wente Exp Ther Med Articles Expression of transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF) in patients with Achilles tendon rupture, and the predictive values and significance in clinical efficacy were explored. Forty-two patients with Achilles tendon rupture, surgically treated in the First Affiliated Hospital of University of South China, were selected and the clinical efficacy was evaluated based on the American Orthopaedic Foot and Ankle Society (AOFAS) scoring system. RT-qPCR was adopted to detect the expression of serum TGF-β1 and VEGF in the patients before and after treatment, and Spearman's correlation was used to analyze the correlation of TGF-β1 and VEGF with the clinical efficacy after treatment. Patients were divided into an excellent efficacy group and a good/general efficacy group according to the predictive efficacy. In the two groups, the expression levels of TGF-β1 and VEGF before treatment were observed, and the predictive values of TGF-β1 and VEGF in clinical efficacy using the receiver operating characteristic (ROC) curves were obtained. The 42 patients showed significantly higher expression of TGF-β1 and VEGF at 3 months after treatment, and significantly decreased expression at 6 months after treatment, compared to the results before treatment (both P<0.001). After treatment, the efficacy was excellent in 11 patients, good in 25 and general in 6. Spearman's correlation analysis revealed that the expression of TGF-β1 and VEGF decreased with the improvement of efficacy after treatment (P<0.001), and the excellent efficacy group showed significantly lower expression of TGF-β1 and VEGF than that in the good/general efficacy group (P<0.01). Moreover, according to ROC curves, the areas under the curves (AUCs) of TGF-β1 and VEGF were 0.651 and 0.645, respectively. In conclusion, TGF-β1 and VEGF can be considered as observational indexes and predictors for clinical efficacy in patients with Achilles tendon rupture, before and after treatment. D.A. Spandidos 2019-11 2019-08-30 /pmc/articles/PMC6777322/ /pubmed/31602226 http://dx.doi.org/10.3892/etm.2019.7968 Text en Copyright: © Cui et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Cui, Juncheng
Chen, Zhiwei
Wu, Wente
Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy
title Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy
title_full Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy
title_fullStr Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy
title_full_unstemmed Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy
title_short Expression of TGF-β1 and VEGF in patients with Achilles tendon rupture and the clinical efficacy
title_sort expression of tgf-β1 and vegf in patients with achilles tendon rupture and the clinical efficacy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777322/
https://www.ncbi.nlm.nih.gov/pubmed/31602226
http://dx.doi.org/10.3892/etm.2019.7968
work_keys_str_mv AT cuijuncheng expressionoftgfb1andvegfinpatientswithachillestendonruptureandtheclinicalefficacy
AT chenzhiwei expressionoftgfb1andvegfinpatientswithachillestendonruptureandtheclinicalefficacy
AT wuwente expressionoftgfb1andvegfinpatientswithachillestendonruptureandtheclinicalefficacy